India, Nov. 19 -- image credit- shutterstock

For people living with chronic kidney disease, dialysis is a long-term commitment that requires consistent access to specialised care. VitusCare, a dialysis care provider focused on expanding access to quality dialysis services across underserved markets, has secured $3 million in a Series B funding participated in by Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors 1Crowd and 3i Partners, and several angel investors.

The funding comes as VitusCare claims strong business growth. Since its previous funding round in late 2024, led by Tomorrow Capital, the company has nearly tripled its revenue. Its network has gr...